抗排斥 CD30.CAR 修饰的 Epstein-Barr 病毒特异性 T 细胞作为治疗 CD30+ 淋巴瘤的现成平台

{"title":"抗排斥 CD30.CAR 修饰的 Epstein-Barr 病毒特异性 T 细胞作为治疗 CD30+ 淋巴瘤的现成平台","authors":"David H. Quach, H. R. Ganesh, Y. D. Briones, N. Nouraee, Audrey Ma, Yezan F. Hadidi, C. Rooney","doi":"10.1016/j.omton.2024.200814","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":516670,"journal":{"name":"Molecular Therapy: Oncology","volume":"227 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rejection resistant CD30.CAR-modified Epstein-Barr virus specific T cells as an off-the-shelf platform for CD30+ lymphoma\",\"authors\":\"David H. Quach, H. R. Ganesh, Y. D. Briones, N. Nouraee, Audrey Ma, Yezan F. Hadidi, C. Rooney\",\"doi\":\"10.1016/j.omton.2024.200814\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":516670,\"journal\":{\"name\":\"Molecular Therapy: Oncology\",\"volume\":\"227 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Therapy: Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.omton.2024.200814\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Therapy: Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.omton.2024.200814","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}